Caribou Biosciences CRBU
NASDAQ CRBU
$1.27 +0.03 (+2.82%)
As of: Sep 30, 2026 · 10:25 AM EDT

Caribou Biosciences (CRBU) Total Current Liabilities (2020 - 2026)

Updated

Caribou Biosciences (CRBU) posted Total Current Liabilities of $17.97 million for Q2 2026, down 37.8% from $28.89 million a year earlier and down 8.6% from the prior quarter.

Analysis

Caribou Biosciences (CRBU) Total Current Liabilities (2020 - 2026) Analysis & Trends

At the end of FY2025, Caribou Biosciences' Total Current Liabilities came in at $25.41 million, down 17.1% from FY2024.

  • Annual Total Current Liabilities shows a five-year compound annual growth rate of 15.5% (FY2020 to FY2025).
  • In prior years, Caribou Biosciences' Total Current Liabilities was $30.65 million in FY2024 (+8.3%), $28.3 million in FY2023 (+0.6%), $28.13 million in FY2022 (+8.9%) and $25.83 million in FY2021 (+108.5%).
  • The Q2 2026 figure stands as the lowest quarterly Total Current Liabilities since Q4 2020.
  • On a year-over-year basis, Total Current Liabilities has declined in each of the last six quarters, with an average decline of 8.5% over the last eight quarters.
  • The strongest year-over-year quarter for Total Current Liabilities in the past five years was Q4 2021, with growth of 108.5%; the weakest was Q2 2026, with a decline of 37.8%.
  • According to Business Quant data, Total Current Liabilities for the three prior quarters was $19.67 million (Q1 2026), $25.41 million (Q4 2025) and $28.06 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 54.90 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 41.64 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -31.55 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.94 Bn
10 Caribou Biosciences 130.37 Mn -386.16 Mn - 17.97 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 17.97 Mn
Mar 31, 2026 19.67 Mn
Dec 31, 2025 25.41 Mn
Sep 30, 2025 28.06 Mn
Jun 30, 2025 28.89 Mn
Mar 31, 2025 28.49 Mn
Dec 31, 2024 30.65 Mn
Sep 30, 2024 32.16 Mn
Jun 30, 2024 30.94 Mn
Mar 31, 2024 29.02 Mn
Dec 31, 2023 28.30 Mn
Sep 30, 2023 24.57 Mn
Jun 30, 2023 34.38 Mn
Mar 31, 2023 27.10 Mn
Dec 31, 2022 28.13 Mn
Sep 30, 2022 28.81 Mn
Jun 30, 2022 28.86 Mn
Mar 31, 2022 26.67 Mn
Dec 31, 2021 25.83 Mn
Sep 30, 2021 26.16 Mn
API Access

Caribou Biosciences Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=CRBU&period=max&api_key=YOUR_API_KEY